is wegovy a glp 1 drug Novo's becomes first GLP-1 approved for MASH Medicare will negotiate Novo's GLP-1
Description
Additional benefits include improved cardiovascular outcomes in those with or at high risk of cardiovascular disease, and renoprotection
According to the SURMOUNT-1 clinical trial, patients using tirzepatide at the highest dose (15 mg weekly) experienced up to 22.5% total body weight loss over 72 weeksgreater than what is typically seen with semaglutide GLP-1
Ayala, J
The dosing schedule follows a similar gradual titration to minimize side effects
Association between obesity and iron deficiency (Review)
This does not mean the medication failed
